HCW Biologics (HCWB) Assets Average (2021 - 2026)

HCW Biologics (HCWB) has reported Assets Average for 6 consecutive years, with $25.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 7.08% year-over-year to $25.6 million; the trailing twelve-month figure through Jun 2026 stood at $25.6 million (down 7.08% YoY), and the FY2025 full-year result was $27.4 million, down 6.8% from the prior year.
• Assets Average improved to $25.6 million in Q2 2026 per HCWB's latest filing, from $25.0 million in the prior quarter.
• Across five years, Assets Average topped out at $52.2 million in Q1 2022 and bottomed at $25.0 million in Q4 2025.
• Historically, Assets Average has averaged $35.5 million across 5 years, with a median of $29.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets Average jumped 42.23% in 2022, then tumbled 34.76% in 2024.
• Over 5 years, Assets Average stood at $49.1 million in 2022, then slumped by 34.67% to $32.1 million in 2023, then declined by 11.44% to $28.4 million in 2024, then decreased by 12.02% to $25.0 million in 2025, then rose by 2.65% to $25.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $25.6 million, $25.0 million, and $27.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.